01-04-2024 | Hyperthyroidism | Case report
Pembrolizumab
Latent hyperthyroidism, immune-related hypothyroidism and hyperthyroidism
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event